Results 151 to 160 of about 19,810 (255)

Atypical Metastatic Disease in Thyroid from Pancreatic Neuroendocrine Tumor and its Response to [177Lu]Lu-DOTATATE Peptide Receptor Radionuclide Therapy (PRRT): A Promising Therapeutic Option for Somatostatin Receptor Expressing Unusual Metastatic Sites [PDF]

Mali Madhava Reddy, Rahul V. Parghane, Sandip Basu   +2 more
openalex   +1 more source

Lu-177-Based Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors [PDF]

, 2017
Keunyoung Kim, Seong‐Jang Kim
openalex   +1 more source

Circulating Tumor DNA Monitoring in Peptide Receptor Radionuclide Therapy-Treated Patients With Gastroenteropancreatic Neuroendocrine Tumors. [PDF]

JCO Precis Oncol
Bogdani C, Karimi A, Li R, Atkinson EC, Oberstein PE, Siolas D.   +5 more
europepmc   +1 more source

Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic origin [PDF]

, 2007
Dik J. Kwekkeboom, Eric P. Krenning, Maarten O. van Aken, Martijn van Essen, Willem H. Bakker, Wouter W. de Herder   +5 more
core   +1 more source

Management of Peptide Receptor Radionuclide Therapy Toxicities in Neuroendocrine Neoplasm Patients. [PDF]

Curr Treat Options Oncol
Mohindroo C, Ramirez RA.
europepmc   +1 more source

Efficacy of Peptide Receptor Radionuclide Therapy for Functional Metastatic Paraganglioma and Pheochromocytoma [PDF]

, 2017
Grace Kong, Simona Grozinsky‐Glasberg, Michael S. Hofman, Jason Callahan, Amichay Meirovitz, Ofra Maimon, David A. Pattison, David J. Gross, Rodney J. Hicks   +8 more
openalex   +1 more source

Peptide Receptor Radionuclide Therapy-Induced Hypercortisolemic Crisis in Ectopic Cushing Syndrome. [PDF]

JCEM Case Rep
Pandit R, Yamichannaiah C, Lila AR, Karlekar M, Memon SS, Bandgar T.   +5 more
europepmc   +1 more source

Safety and efficacy of peptide receptor radionuclide therapy for advanced medullary thyroid cancer: a systematic review and meta-analysis. [PDF]

Thyroid Res
Abdlkadir AS, Al-Adhami D, Shi H, Sathekge MM, Sheikha AA, Mohamad I, Kreissl M, Al-Ibraheem A.   +7 more
europepmc   +1 more source

¹⁷⁷Lu-labelled peptide receptor radionuclide therapy in patients with neuroendocrine tumors: a systematic review and meta-analysis. [PDF]

Front Endocrinol (Lausanne)
Wang J, Pang X, Lian J, Lu H.
europepmc   +1 more source

Prevention and Management of Peptide Receptor Radionuclide Therapy-Induced Hypertensive Crisis in a Patient With Metastatic Pheochromocytoma. [PDF]

AACE Endocrinol Diabetes
Yu R, Gardner L, Salavati A, Bahri S.
europepmc   +1 more source